17-alpha hydroxyprogesterone caproate and risk for venous thromboembolism during pregnancy

Schuster, M., Ananth, C. V., Gomez, D., Huang, Y., Gyamfi-Bannerman, C., Wright, J. D., D’Alton, M. E., & Friedman, A. M. (2021). 17-alpha hydroxyprogesterone caproate and risk for venous thromboembolism during pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine, 35(25), 6336–6337. https://doi.org/10.1080/14767058.2021.1911997
Authors:
Meike Schuster
Cande V Ananth
Daniela Gomez
Yongmei Huang
Cynthia Gyamfi-Bannerman
Jason D Wright
Mary E D'Alton
Alexander M Friedman
Affiliated Authors:
Yongmei Huang
Cynthia Gyamfi-Bannerman
Jason D Wright
Mary E D'Alton
Alexander M Friedman
Columbia Affiliation:
Subjects:
Venous Thromboembolism (MeSH)
Premature Birth (MeSH)
Author Keywords:
17-alpha hydroxyprogesterone caproate
obstetric thromboembolism
maternal complications
elink
Publication Type:
Article
Unique ID:
10.1080/14767058.2021.1911997
PMID:
33855933
DOI:
10.1080/14767058.2021.1911997
Journal:
Journal of Maternal-Fetal and Neonatal Medicine
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: